SMTL ID : 1zgv.1

Thrombin in complex with an oxazolopyridine inhibitor 2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-oligomer

Ligands

1 x 501: N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE(Non-covalent)

501.1: 17 residues within 4Å: Chain A: H.72, Y.76, W.79, D.228, A.229, C.230, E.231, S.234, V.254, S.255, W.256, G.257, G.259, C.260, G.267, F.268, Y.269 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.76, A:W.79, A:V.254, A:W.256, A:W.256 Hydrogen bonds: A:S.234, A:S.234, A:G.257, A:G.257

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Deng, J.Z. et al., Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimization. Bioorg.Med.Chem.Lett. (2005)

Release Date

2005-09-27

Peptides

Thrombin: A
Hirudin: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Thrombin

Hirudin

Related Entries With Identical Sequence